Zeta Corporation

Zeta Corporation is a leading biomedical company, ISO 13485:2016 and FDA registered, specializing in the manufacture and distribution of IVD antibodies for Pathology/IHC. With over 75 years of collective knowledge, Zeta produces the highest-quality antibodies to aid pathologists in diagnosing human tumors and diseases. Zeta's antibodies are meticulously curated to provide reproducible results on formalin-fixed, paraffin-embedded sections.

They can be used manually or with automated equipment. The company utilizes cutting-edge technology to design and develop tumor-specific biomarkers for their renowned RAbMono™ (Rabbit Monoclonal) and MonoMAb™ (Monospecific monoclonal antibodies). These antibodies are produced using hybridoma and recombinant technologies, ensuring high sensitivity and specificity.

Zeta Corporation sells its products directly in the US and distributes them globally to over 50 countries through trusted partners. Their CE-IVD labeled products comply with European regulatory standards, and they support clients and distributors in obtaining quality approvals. By providing the highest-quality diagnostic IVD antibodies, Zeta is dedicated to assisting in the diagnosis, targeted therapy, and differential diagnosis of human diseases.

Join their team to contribute to their mission of becoming a global leader in target-validated and characterized IVD antibodies for Pathology and IHC. Contact Zeta Corporation for more information